Using monoclonal antibodies and flow cytometry, wer serially monitored lymphocyte subpopulations in renal-allograft recipients treated with either conventional immunosuppression or a monoclonal antibody. In 29 patients given conventional suppression, highly significant correlations between changes in T-cell subsets and rejection were noted. Normal or elevated ratios of OKT4 (helper/inducer) to OKT8 (suppressor/cytotoxic) cells were associated with rejection unless the donor was HLA identical or the total number of T cells was extremely low. In patients with low ratios, rejection seldom occurred. Two patients treated with OKT3 monoclonal antibody for acute rejection had rapid disappearance of OKT3-reactive cells from the peripheral blood and prompt reversal of rejection. The use of monoclonal antibodies allows the precise determination of changes in T-cell subsets and promises the development of therapeutic protocols that can be designed to manipulate selected lymphocyte populations.
This article has been cited by other articles:
Bhorade, S. M., Stern, E.
(2009). Immunosuppression for Lung Transplantation. Proc Am Thorac Soc
6: 47-53
[Abstract][Full Text]
Isaacs, J. D.
(2008). Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future. Rheumatology (Oxford)
47: 1461-1468
[Abstract][Full Text]
Steffens, S., Burger, F., Pelli, G., Dean, Y., Elson, G., Kosco-Vilbois, M., Chatenoud, L., Mach, F.
(2006). Short-Term Treatment With Anti-CD3 Antibody Reduces the Development and Progression of Atherosclerosis in Mice. Circulation
114: 1977-1984
[Abstract][Full Text]
Yang, W., Hussain, S., Mi, Q.-S., Santamaria, P., Delovitch, T. L.
(2004). Perturbed Homeostasis of Peripheral T Cells Elicits Decreased Susceptibility to Anti-CD3-Induced Apoptosis in Prediabetic Nonobese Diabetic Mice. J. Immunol.
173: 4407-4416
[Abstract][Full Text]
Pascual, M., Theruvath, T., Kawai, T., Tolkoff-Rubin, N., Cosimi, A. B.
(2002). Strategies to Improve Long-Term Outcomes after Renal Transplantation. NEJM
346: 580-590
[Full Text]
von Herrath, M. G., Coon, B., Wolfe, T., Chatenoud, L.
(2002). Nonmitogenic CD3 Antibody Reverses Virally Induced (Rat Insulin Promoter-Lymphocytic Choriomeningitis Virus) Autoimmune Diabetes Without Impeding Viral Clearance. J. Immunol.
168: 933-941
[Abstract][Full Text]
Nishikido, M., Kiyohara, T., Koga, S., Shindo, K., Matsuya, F., Saito, Y., Kanetake, H.
(2001). OK432-induced killer cell activity: potential method for monitoring immunological complications after renal transplantation. Nephrol Dial Transplant
16: 2067-2071
[Abstract][Full Text]
Chung, D. H., Belyakov, I. M., Derby, M. A., Wang, J., Boyd, L. F., Berzofsky, J. A., Margulies, D. H.
(2001). Competitive Inhibition In Vivo and Skewing of the T Cell Repertoire of Antigen-Specific CTL Priming by an Anti-Peptide-MHC Monoclonal Antibody. J. Immunol.
167: 699-707
[Abstract][Full Text]
Wain, J. C., Wright, C. D., Ryan, D. P., Zorb, S. L., Mathisen, D. J., Ginns, L. C.
(1999). Induction immunosuppression for lung transplantation with OKT3. Ann. Thorac. Surg.
67: 187-193
[Abstract][Full Text]
Shiraishi, T., Mizuta, T., DeMeester, S. R., Ritter, J. H., Swanson, P. E., Wick, M. R., Cooper, J. D., Patterson, G. A.
(1995). Effect of Ischemic Injury on Subsequent Rat Lung Allograft Rejection. Ann. Thorac. Surg.
60: 947-951
[Abstract][Full Text]
Wolf, G. T., Schmaltz, S., Hudson, J., Robson, H., Stackhouse, T., Peterson, K. A., Poore, J. A., McClatchey, K. D.
(1987). Alterations in T-Lymphocyte Subpopulations in Patients With Head and Neck Cancer: Correlations With Prognosis. Arch Otolaryngol Head Neck Surg
113: 1200-1206
[Abstract]
Chatenoud, L, Jonker, M, Villemain, F, Goldstein, G, Bach, J.
(1986). The human immune response to the OKT3 monoclonal antibody is oligoclonal. Science
232: 1406-1408
[Abstract]
Wolf, G. T., Lovett, E. J. III, Peterson, K. A., Beauchamp, M. L., Baker, S. R.
(1984). Lymphokine Production and Lymphocyte Subpopulations in Patients With Head and Neck Squamous Carcinoma. Arch Otolaryngol Head Neck Surg
110: 731-735
[Abstract]